Late failure of combined recombinant hepatitis B vaccine and lamivudine in treatment of a patient with chronic hepatitis B
dc.contributor.author | Yalcin, K | |
dc.contributor.author | Degertekin, H | |
dc.contributor.author | Bozdayi, M | |
dc.date.accessioned | 2024-04-24T17:08:14Z | |
dc.date.available | 2024-04-24T17:08:14Z | |
dc.date.issued | 2004 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | We report the first case of a woman having chronic hepatitis B treated with a combination therapy of recombinant hepatitis B vaccine and lamivudine for 18 months. The main aims of such a combined therapy were to assess whether the concomitant anti-hepatitis B virus (HBV) vaccination might prevent the emergence of a mutant HBV and lead to sustained hepatitis B e antigen seroconversion with undetectable serum HBV DNA. The data from the present case demonstrated that combination of anti-HBV vaccine and lamivudine did not eliminate viral DNA despite prolonged treatment and did not have any effect on preventing resistant-type HBV. Although the combined therapy failed to reach the therapeutic endpoints, it concerned a single and unique patient. Hepatitis B vaccine and lamivudine for HBV treatment should be further investigated in randomized controlled trials. | en_US |
dc.identifier.doi | 10.1097/01.SMJ.0000091068.87861.BA | |
dc.identifier.endpage | 409 | en_US |
dc.identifier.issn | 0038-4348 | |
dc.identifier.issn | 1541-8243 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 15108839 | |
dc.identifier.scopus | 2-s2.0-1842730628 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 407 | en_US |
dc.identifier.uri | https://doi.org/10.1097/01.SMJ.0000091068.87861.BA | |
dc.identifier.uri | https://hdl.handle.net/11468/17260 | |
dc.identifier.volume | 97 | en_US |
dc.identifier.wos | WOS:000222172200021 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Southern Medical Journal | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hepatitis B | en_US |
dc.subject | Lamivudine | en_US |
dc.subject | Recombinant Vaccine | en_US |
dc.title | Late failure of combined recombinant hepatitis B vaccine and lamivudine in treatment of a patient with chronic hepatitis B | en_US |
dc.title | Late failure of combined recombinant hepatitis B vaccine and lamivudine in treatment of a patient with chronic hepatitis B | |
dc.type | Article | en_US |